Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jan-Ole Werner
HLA Ligandome Analysis of Primary Chronic Lymphocytic Leukemia (CLL) Cells Under Lenalidomide Treatment Confirms the Suitability of Lenalidomide for Combination With T-Cell-Based Immunotherapy
OncoImmunology
Oncology
Allergy
Immunology
Related publications
Treatment With Lenalidomide Modulates T-Cell Immunophenotype and Cytokine Production in Patients With Chronic Lymphocytic Leukemia
Cancer
Cancer Research
Oncology
HLA Ligandome Analysis Identifies the Underlying Specificities of Spontaneous Antileukemia Immune Responses in Chronic Lymphocytic Leukemia (CLL)
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Management of Patients With Chronic Lymphocytic Leukemia Treated With Lenalidomide
Clinical Journal of Oncology Nursing
Oncology
Immune Dysfunction in Chronic Lymphocytic Leukemia T Cells and Lenalidomide as an Immunomodulatory Drug
Haematologica
Hematology
Consolidation Treatment With Lenalidomide Following Front-Line or Salvage Chemoimmunotherapy in Chronic Lymphocytic Leukemia
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Analysis of Treatment Options for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Immunotherapy in Chronic Lymphocytic Leukaemia (CLL)
Current Hematologic Malignancy Reports
Cancer Research
Oncology
Hematology
Lenalidomide-Induced Graft-Vs.-Leukemia Effect in a Patient With Chronic Lymphocytic Leukemia Who Relapsed After Allogeneic Stem Cell Transplant
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Accelerating CAR Therapy in CLL: The Development and Challenges of CAR T Cell Therapy for Chronic Lymphocytic Leukemia
American Journal of Hematology
Hematology
